{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,26]],"date-time":"2026-02-26T15:50:39Z","timestamp":1772121039479,"version":"3.50.1"},"reference-count":26,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2008,3,1]],"date-time":"2008-03-01T00:00:00Z","timestamp":1204329600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2008,3,1]],"date-time":"2008-03-01T00:00:00Z","timestamp":1204329600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jaad.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the American Academy of Dermatology"],"published-print":{"date-parts":[[2008,3]]},"DOI":"10.1016\/j.jaad.2007.12.014","type":"journal-article","created":{"date-parts":[[2008,2,15]],"date-time":"2008-02-15T07:53:39Z","timestamp":1203062019000},"page":"382-386","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"title":["Increased cancer antigen 27.29 (CA27.29) level in patients with mycosis fungoides"],"prefix":"10.1016","volume":"58","author":[{"given":"Putao","family":"Cen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Madeleine","family":"Duvic","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Philip R.","family":"Cohen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Razelle","family":"Kurzrock","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jaad.2007.12.014_bib1","doi-asserted-by":"crossref","first-page":"2385","DOI":"10.1182\/blood.V88.7.2385.bloodjournal8872385","article-title":"Mycosis fungoides and S\u00e9zary syndrome","volume":"88","author":"Diamandidou","year":"1996","journal-title":"Blood"},{"key":"10.1016\/j.jaad.2007.12.014_bib2","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1111\/j.1365-2230.2005.02019.x","article-title":"Staging and management of cutaneous T-cell lymphoma","volume":"31","author":"Scarisbrick","year":"2006","journal-title":"Clin Exp Dermatol"},{"key":"10.1016\/j.jaad.2007.12.014_bib3","doi-asserted-by":"crossref","first-page":"914","DOI":"10.1016\/S0190-9622(99)70079-4","article-title":"Prognostic factor analysis in mycosis fungoides\/S\u00e9zary syndrome","volume":"40","author":"Diamandidou","year":"1999","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaad.2007.12.014_bib4","doi-asserted-by":"crossref","first-page":"1150","DOI":"10.1182\/blood.V92.4.1150","article-title":"Transformation of mycosis fungoides\/S\u00e9zary syndrome: clinical characteristics and prognosis","volume":"92","author":"Diamandidou","year":"1998","journal-title":"Blood"},{"key":"10.1016\/j.jaad.2007.12.014_bib5","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1016\/0304-4157(95)00014-3","article-title":"The epithelial mucin, MUC1, of milk, mammary gland and other tissues","volume":"1241","author":"Patton","year":"1995","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.jaad.2007.12.014_bib6","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1002\/ijc.2910630319","article-title":"Heterogeneity in production, secretion and glycosylation of MUC1 epithelial mucin by primary cultures of ovarian carcinoma","volume":"63","author":"McGuckin","year":"1995","journal-title":"Int J Cancer"},{"key":"10.1016\/j.jaad.2007.12.014_bib7","first-page":"5476","article-title":"Development and characterization of breast cancer reactive monoclonal antibodies directed to the core protein of the human milk mucin","volume":"47","author":"Burchell","year":"1987","journal-title":"Cancer Res"},{"key":"10.1016\/j.jaad.2007.12.014_bib8","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1023\/A:1026110417294","article-title":"Tissue and serum MUC1 mucin detection in breast cancer patients","volume":"81","author":"Croce","year":"2003","journal-title":"Breast Cancer Res Treat"},{"key":"10.1016\/j.jaad.2007.12.014_bib9","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/S0959-8049(00)00396-8","article-title":"CA27.29: a valuable marker for breast cancer management; a confirmatory multicentric study on 603 cases","volume":"37","author":"Gion","year":"2001","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.jaad.2007.12.014_bib10","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1067\/mjd.2003.449","article-title":"Analysis of long-term outcomes of combined modality therapy for cutaneous T-cell lymphoma","volume":"49","author":"Duvic","year":"2003","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaad.2007.12.014_bib11","doi-asserted-by":"crossref","first-page":"1022","DOI":"10.1016\/S0190-9622(96)90282-0","article-title":"Combined modality therapy for cutaneous T-cell lymphoma","volume":"34","author":"Duvic","year":"1996","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaad.2007.12.014_bib12","first-page":"6846","article-title":"The epithelial tumor antigen MUC1 is expressed in hematological malignancies and is recognized by MUC1-specific cytotoxic T-lymphocytes","volume":"61","author":"Brossart","year":"2001","journal-title":"Cancer Res"},{"key":"10.1016\/j.jaad.2007.12.014_bib13","doi-asserted-by":"crossref","first-page":"4309","DOI":"10.1182\/blood.V93.12.4309","article-title":"Identification of HLA-A2-restricted T-cell epitopes derived from the MUC1 tumor antigen for broadly applicable vaccine therapies","volume":"93","author":"Brossart","year":"1999","journal-title":"Blood"},{"key":"10.1016\/j.jaad.2007.12.014_bib14","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/S0145-2126(00)00111-9","article-title":"MUC1 expression in plasmacytoma","volume":"25","author":"Paydas","year":"2001","journal-title":"Leuk Res"},{"key":"10.1016\/j.jaad.2007.12.014_bib15","doi-asserted-by":"crossref","first-page":"3147","DOI":"10.1182\/blood.V96.9.3147","article-title":"Elevated soluble MUC1 levels and decreased anti-MUC1 antibody levels in patients with multiple myeloma","volume":"96","author":"Treon","year":"2000","journal-title":"Blood"},{"key":"10.1016\/j.jaad.2007.12.014_bib16","doi-asserted-by":"crossref","first-page":"2102","DOI":"10.4049\/jimmunol.153.5.2102","article-title":"Expression of MUC1 on myeloma cells and induction of HLA-unrestricted CTL against MUC1 from a multiple myeloma patient","volume":"153","author":"Takahashi","year":"1994","journal-title":"J Immunol"},{"key":"10.1016\/j.jaad.2007.12.014_bib17","doi-asserted-by":"crossref","DOI":"10.4049\/jimmunol.151.7.3693","article-title":"Cytotoxic T cells from ovarian malignant tumors can recognize polymorphic epithelial mucin core peptides","volume":"151","author":"Ioannides","year":"1993","journal-title":"J Immunol"},{"key":"10.1016\/j.jaad.2007.12.014_bib18","doi-asserted-by":"crossref","first-page":"767","DOI":"10.4049\/jimmunol.151.2.767","article-title":"Episialin (MUC1) inhibits cytotoxic lymphocyte-target cell interaction","volume":"151","author":"van de Wiel-van Kemenade","year":"1993","journal-title":"J Immunol"},{"key":"10.1016\/j.jaad.2007.12.014_bib19","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1006\/cimm.2000.1643","article-title":"The epithelial mucin, MUC1, is expressed on resting T lymphocytes and can function as a negative regulator of T cell activation","volume":"201","author":"Chang","year":"2000","journal-title":"Cell Immunol"},{"key":"10.1016\/j.jaad.2007.12.014_bib20","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1038\/nm0198-043","article-title":"Cancer-associated MUC1 mucin inhibits human T-cell proliferation, which is reversible by IL-2","volume":"4","author":"Agrawal","year":"1998","journal-title":"Nat Med"},{"key":"10.1016\/j.jaad.2007.12.014_bib21","first-page":"4079","article-title":"Expression of MUC1 mucin on activated human T cells: implications for a role of MUC1 in normal immune regulation","volume":"58","author":"Agrawal","year":"1998","journal-title":"Cancer Res"},{"key":"10.1016\/j.jaad.2007.12.014_bib22","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1093\/intimm\/dxh219","article-title":"MUC1 mucin-mediated regulation of human T cells","volume":"17","author":"Agrawal","year":"2005","journal-title":"Int Immunol"},{"key":"10.1016\/j.jaad.2007.12.014_bib23","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1006\/cimm.1997.1085","article-title":"A MUC1 mucin secreted from a colon carcinoma cell line inhibits target cell lysis by natural killer cells","volume":"176","author":"Zhang","year":"1997","journal-title":"Cell Immunol"},{"key":"10.1016\/j.jaad.2007.12.014_bib24","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1097\/00002371-199701000-00008","article-title":"Prognostic significance of preimmunotherapy serum CA27.29 (MUC-1) mucin level after active specific immunotherapy of metastatic adenocarcinoma patients","volume":"20","author":"MacLean","year":"1997","journal-title":"J Immunother"},{"key":"10.1016\/j.jaad.2007.12.014_bib25","doi-asserted-by":"crossref","first-page":"1130","DOI":"10.1038\/sj.bjc.6601267","article-title":"An anti-MUC1-antibody-interleukin-2 fusion protein that activates resting NK cells to lysis of MUC1-positive tumor cells","volume":"89","author":"Heuser","year":"2003","journal-title":"Br J Cancer"},{"key":"10.1016\/j.jaad.2007.12.014_bib26","doi-asserted-by":"crossref","first-page":"2132","DOI":"10.1182\/blood-2004-01-0366","article-title":"Enrichment of functional CD8 memory T cells specific for MUC1 in bone marrow of patients with multiple myeloma","volume":"105","author":"Choi","year":"2005","journal-title":"Blood"}],"container-title":["Journal of the American Academy of Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0190962207024267?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0190962207024267?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,30]],"date-time":"2025-09-30T22:11:30Z","timestamp":1759270290000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0190962207024267"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,3]]},"references-count":26,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2008,3]]}},"alternative-id":["S0190962207024267"],"URL":"https:\/\/doi.org\/10.1016\/j.jaad.2007.12.014","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.1157274.617413","asserted-by":"object"}]},"ISSN":["0190-9622"],"issn-type":[{"value":"0190-9622","type":"print"}],"subject":[],"published":{"date-parts":[[2008,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Increased cancer antigen 27.29 (CA27.29) level in patients with mycosis fungoides","name":"articletitle","label":"Article Title"},{"value":"Journal of the American Academy of Dermatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jaad.2007.12.014","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2008 American Academy of Dermatology, Inc. Published by Mosby, Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}